Gene signatures of drug resistance predict patient survival in colorectal cancer
about
Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets?A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sources.Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.Chemotherapy outcome predictive effectiveness by the Oncogramme: pilot trial on stage-IV colorectal cancerIdentifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post-chemotherapy tissuesTranslationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.Novel Holistic Approaches for Overcoming Therapy Resistance in Pancreatic and Colon Cancers.Computational models for predicting drug responses in cancer research.Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy.SNRFCB: sub-network based random forest classifier for predicting chemotherapy benefit on survival for cancer treatment.Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity.Epigenetic changes in histone acetylation underpin resistance to the topoisomerase I inhibitor irinotecan.Inferences of individual drug responses across diverse cancer types using a novel competing endogenous RNA network.Proteomic approach toward determining the molecular background of pazopanib resistance in synovial sarcoma.
P2860
Q28088454-1D8EA0E3-39C0-4D0B-900C-4933D5240794Q31056926-8B3B89CB-B2D0-4DFD-9F4F-947F0707F29FQ35955331-3F3E61B5-00CD-419E-93AC-6C3380D324ABQ36485454-448E1078-01F2-4573-96CE-86AC10029967Q36562337-A4C200E7-9085-422B-92F8-10AEB25C32AFQ37618598-DA1A960C-5671-4F5D-989A-537C129FB8F1Q38558090-F648E7E6-E8F9-4586-8DC3-CE86F8C3724DQ38904995-A82F2344-7B17-412F-BD2C-D80FDC20D3B9Q39590420-01B02BED-8C78-4367-B101-E96F6F139FD1Q40007032-D2C95DF7-CD07-448A-8032-F5A400AA82A5Q41943341-C39C63C1-1DE9-41FA-BF2C-490C03523FC8Q42065258-EEBC313D-E63E-4E1A-9F17-A021F3049AF0Q49719068-8B282A80-85E9-4F8F-AAE2-6AAE468D71C8Q50129409-8C3A7352-3966-4A33-8ADB-4E542ADFDC2B
P2860
Gene signatures of drug resistance predict patient survival in colorectal cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Gene signatures of drug resistance predict patient survival in colorectal cancer
@ast
Gene signatures of drug resistance predict patient survival in colorectal cancer
@en
type
label
Gene signatures of drug resistance predict patient survival in colorectal cancer
@ast
Gene signatures of drug resistance predict patient survival in colorectal cancer
@en
prefLabel
Gene signatures of drug resistance predict patient survival in colorectal cancer
@ast
Gene signatures of drug resistance predict patient survival in colorectal cancer
@en
P2860
P356
P1476
Gene signatures of drug resistance predict patient survival in colorectal cancer
@en
P2860
P2888
P304
P356
10.1038/TPJ.2014.45
P50
P577
2014-09-02T00:00:00Z